Psychosocial factors and medication adherence among patients with coronary heart disease: A text messaging intervention

European Journal of Cardiovascular Nursing

Volumn 14, Issue 3, 2015, Pages 264-273

  Park, Linda G ^a   Howie Esquivel, Jill ^a   Whooley, Mary A ^a,b   Dracup, Kathleen ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

coronary heart disease; depression; Medication adherence; mobile health; self efficacy; social support; text messaging

Indexed keywords

ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; CARDIOTONIC AGENT;

ADULT; AGE; AGED; ARTICLE; CARDIAC PATIENT; CONTROLLED STUDY; DEPRESSION; EDUCATION; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEALTH EDUCATION; HUMAN; INTERVENTION STUDY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SELF MEDICATION; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; TEXT MESSAGING; TREATMENT RESPONSE; ANGIOCARDIOGRAPHY; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; PROGNOSIS; PSYCHOLOGY; RADIOGRAPHY; REMINDER SYSTEM; RISK ASSESSMENT; SELF CONCEPT; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TELEMEDICINE; TIME; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARDIOTONIC AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PSYCHOLOGY; REMINDER SYSTEMS; RISK ASSESSMENT; SELF EFFICACY; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TELEMEDICINE; TEXT MESSAGING; TIME FACTORS; TREATMENT OUTCOME;

EID: 84930429488     PISSN: 14745151     EISSN: 18731953     Source Type: Journal    
DOI: 10.1177/1474515114537024     Document Type: Article

References (55)

1. World Health Organization. The global burden of disease: 2004 Update, www.who.int/healthinfo/global-burden-disease/GBD-report-2004update-full.pdf (2004, accessed 28 March 2013).
2. Dunbar-Jacob J, Bohachick P, Mortinmer MK, et al. Medication adherence in persons with cardiovascular disease. J Cardiov Nurs. 2003 ; 18: 209-218
3. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: Its importance in cardiovascular outcomes. Circulation. 2009 ; 119: 3028-3035
4. Ho PM, Magid DJ, Shetterly SM, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Amer Heart J. 2008 ; 155: 772-779
5. Jneid H, Anderson JL, Wright RS, et al. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2012 ; 60: 645-681
6. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013 ; 127: e362 - e425
7. Smith SC, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 Update. Circulation. 2006 ; 113 (19). 2363-2372
8. Bosworth HB, Granger BB, Mendys P, et al. Medication adherence: A call for action. Amer Heart J. 2011 ; 162: 412-24
9. Brown MT, Bussell JK. Medication adherence: WHO cares?. Mayo Clin Proc. 2011 ; 86: 304-314
10. Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008 ; 2:
11. Bandura A Social foundation of thought and action. Englewood Cliffs, New Jersey: Prentice Hall ; 1987:
12. Bandura A Self-efficacy: The exercise of control. New York: Freeman ; 1997:
13. Clark NM, Dodge JA. Exploring self-efficacy as a predictor of disease management. Health Educ Behav. 1999 ; 26: 72-89
14. Sol BGM, van der Graaf Y, van Petersen R, et al. The effect of self-efficacy on cardiovascular lifestyle. Eur J Cardiov Nurs. 2011 ; 10: 180-186
15. Bandura A. Self-efficacy mechanism in human agency. Am Psychol. 1982 ; 37: 122-147
16. Schedlbauer A, Schroeder K, Peters T, et al. Interventions to improve adherence to lipid lowering medication. Cochrane Database Syst Rev. 2004 ; 4:
17. Warren-Findlow J, Seymour R, Brunner Huber L. The association between self-efficacy and hypertension self-care activities among African American adults. J Comm Health. 2012 ; 37: 15-24
18. Criswell TJ, Weber CA, Xu Y, et al. Effect of self-efficacy and social support on adherence to antihypertensive drugs. Pharmacotherapy. 2010 ; 30: 432-441
19. Gatti ME, Jacobson KL, Gazmararian JA, et al. Relationships between beliefs about medications and adherence. Am J Health Syst Pharm. 2009 ; 66: 657-664
20. Ho PM, Spertus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006 ; 166: 1842-1847
21. Maddox TM, Ho PM. Medication adherence and the patient with coronary artery disease: Challenges for the practitioner. Curr Opin Card. 2009 ; 24: 468-472
22. Mann D, Allegrante J, Natarajan S, et al. Predictors of adherence to statins for primary prevention. Cardiov Drug Ther. 2007 ; 21: 311-316
23. Franklin V, Waller A, Pagliari C, et al. "Sweet Talk": Text messaging support for intensive insulin therapy for young people with diabetes. Diabetes Technol Ther. 2003 ; 5: 991-996
24. Gallagher R, Luttik ML, Jaarsma T. Social support and self-care in heart failure. J Cardiovasc Nurs. 2011 ; 26: 439-445
25. Lester RT, Ritvo P, Mills EJ, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): A randomised trial. Lancet. 2010 ; 376: 1838-1845
26. Bane C, Hughes CM, McElnay JC. The impact of depressive symptoms and psychosocial factors on medication adherence in cardiovascular disease. Patient Educ Couns. 2006 ; 60: 187-193
27. Dempe C, Junger J, Hoppe S, et al. Association of anxious and depressive symptoms with medication nonadherence in patients with stable coronary artery disease. J Psychosom Res. 2013 ; 74: 122-127
28. Gehi A, Haas D, Pipkin S, et al. Depression and medication adherence in outpatients with coronary heart disease: Findings from the Heart and Soul Study. Arch Intern Med. 2005 ; 165: 2508-2513
29. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet. 2004 ; 364: 937-952
30. De Jongh T, Gurol-Urganci I, Vodopivec-Jamsek V, et al. Mobile phone messaging telemedicine for facilitating self management of long-term illnesses. Cochrane Database Syst Rev. 2008 ; 4:
31. Risser J, Jacobson TA, Kripalani S. Development and psychometric evaluation of the self-efficacy for appropriate medication use scale (SEAMS) in low-literacy patients with chronic disease. J Nurs Meas. 2007 ; 15: 203-219
32. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991 ; 32: 705-714
33. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiat. 1961 ; 4: 561-571
34. Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psychol Rev. 1988 ; 8: 77-100
35. Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008 ; 10: 348-354
36. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. PLoS Medicine. 2010 ; 7: e1000251
37. Park LG, Howie-Esquivel J, Chung ML, et al. A text messaging intervention to promote medication adherence among patients with coronary heart disease. Patient Educ Couns. 2014 ; 94: 261-268
38. Castano PM, Bynum JY, Andres R, et al. Effect of daily text messages on oral contraceptive continuation: A randomized controlled trial. Obstet Gynecol. 2012 ; 119: 14-20
39. Mbuagbaw L, Thabane L, Ongolo-Zogo P, et al. The Cameroon Mobile Phone SMS (CAMPS) trial: A randomized trial of text messaging versus usual care for adherence to antiretroviral therapy. PLoS One. 2012 ; 7: e46909
40. Montes JM, Medina E, Gomez-Beneyto M, et al. A short message service (SMS)-based strategy for enhancing adherence to antipsychotic medication in schizophrenia. Psychiat Res. 2012 ; 200: 89-95
41. Suffoletto B, Calabria J, Ross A, et al. A mobile phone text message program to measure oral antibiotic use and provide feedback on adherence to patients discharged from the emergency department. Acad Emerg Med. 2012 ; 19: 949-958
42. Albus C. Psychological and social factors in coronary heart disease. Ann Med. 2010 ; 42: 487-494
43. Vieweg WV, Julius DA, Fernandez A, et al. Treatment of depression in patients with coronary heart disease. Am J Med. 2006 ; 119: 567-573
44. May HT, Sheng X, Catinella AP, et al. Antilipidemic adherence post-coronary artery disease diagnosis among those with and without an ICD-9 diagnosis of depression. J Psychosom Res. 2010 ; 69: 169-174
45. Rieckmann N, Gerin W, Kronish IM, et al. Course of depressive symptoms and medication adherence after acute coronary syndromes: An electronic medication monitoring study. J Amer Coll Card. 2006 ; 48: 2218-2222
46. Freedland KE, Carney RM. Depression as a risk factor for adverse outcomes in coronary heart disease. BMC Med. 2013 ; 11: 131
47. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: The Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. J Am Med Assoc. 2003 ; 289: 3106-3116
48. Barth J, Schneider S, von Kanel R. Lack of social support in the etiology and the prognosis of coronary heart disease: A systematic review and meta-analysis. Psychosom Med. 2010 ; 72: 229-238
49. Lett HS, Blumenthal JA, Babyak MA, et al. Social support and prognosis in patients at increased psychosocial risk recovering from myocardial infarction. Health Psychol. 2007 ; 26: 418-427
50. Leifheit-Limson EC, Reid KJ, Kasl SV, et al. The role of social support in health status and depressive symptoms after acute myocardial infarction: Evidence for a stronger relationship among women. Circ Cardiovasc Qual Outcomes. 2010 ; 3: 143-150
51. Uchino BN. Social support and health: A review of physiological processes potentially underlying links to disease outcomes. J Behav Med. 2006 ; 29: 377-387
52. Molloy GJ, Perkins-Porras L, Strike PC, et al. Social networks and partner stress as predictors of adherence to medication, rehabilitation attendance, and quality of life following acute coronary syndrome. Health Psychol. 2008 ; 27: 52-58
53. Shalansky SJ, Levy AR, Ignaszewski AP. Self-reported Morisky score for identifying nonadherence with cardiovascular medications. Ann Pharmacother. 2004 ; 38: 1363-1368
54. Antypas K, Wangberg SC. E-rehabilitation - an Internet and mobile phone based tailored intervention to enhance self-management of cardiovascular disease: Study protocol for a randomized controlled trial. BMC Cardiovasc Disord. 2012 ; 12: 50
55. Riley WT, Rivera DE, Atienza AA, et al. Health behavior models in the age of mobile interventions: Are our theories up to the task?. Transl Behav Med. 2011 ; 1: 53-71